Cetera Advisors LLC Virios Therapeutics, Inc. Transaction History

Cetera Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.31 - $0.84 $514 - $1,393	-1,659 Reduced 12.23%	11,901 $5,000
Q2 2023 Aug 09, 2023	SELL	$0.35 - $1.94 $2,437 - $13,510	-6,964 Reduced 33.93%	13,560 $18,000
Q4 2022 Feb 14, 2023	SELL	$0.24 - $0.39 $5,620 - $9,133	-23,420 Reduced 53.3%	20,524 $4,000
Q1 2022 May 12, 2022	BUY	$4.48 - $6.92 $35,544 - $54,903	7,934 Added 22.03%	43,944 $197,000
Q4 2021 Feb 14, 2022	SELL	$4.07 - $6.12 $50,557 - $76,022	-12,422 Reduced 25.65%	36,010 $184,000
Q3 2021 Nov 16, 2021	BUY	$4.61 - $6.56 $111,635 - $158,856	24,216 Added 100.0%	48,432 $256,000
Q2 2021 Aug 13, 2021	BUY	$4.71 - $6.95 $3,264 - $4,816	693 Added 2.95%	24,216 $152,000
Q1 2021 May 17, 2021	BUY	$5.01 - $8.84 $117,850 - $207,943	23,523 New	23,523 $135,000

1.12M

Ticker VIRI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,330,400
Market Cap $81.4M
Description
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.